May 6 (Bloomberg) -- Prolor Biotech Inc. declined to the lowest level in almost three weeks after the developer of therapeutic proteins said its first-quarter loss widened.
The shares dropped 2.6 percent to 19.90 shekels at 10:42 a.m. in Tel Aviv, the lowest intraday level since April 16, giving the company a market value of 1.09 billion shekels ($287 million). The TA-25 index declined 1.5 percent today.
Prolor’s loss widened to $4.99 million from $3.46 million in the same period last year.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at firstname.lastname@example.org
To contact the editor responsible for this story: Claudia Maedler at email@example.com